Keisuke Takahata

Chiba, 2638555, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications

Remote network for cognitive symptoms derived from tau accumulation in progressive supranuclear palsy.

Remote network for cognitive symptoms derived from tau accumulation in progressive supranuclear palsy.

Journal: Science advances
Published: July 10, 2026

Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.

Spatiotemporal Tau Accumulation and its Clinical Impact on Progressive Supranuclear Palsy: Longitudinal Florzolotau (18F) Positron Emission Tomography.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 09, 2026

High prevalence of tau pathologies in late-onset psychosis: A PET study.

High prevalence of tau pathologies in late-onset psychosis: A PET study.

Journal: Molecular psychiatry
Published: December 21, 2025

Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy.

Florzolotau (18F) retention is linked to neuropsychological performance in tauopathy.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 11, 2025

Remote Cortical Network for Frontal Cognitive Symptoms Derived from Tau Accumulation in Progressive Supranuclear Palsy.

Remote Cortical Network for Frontal Cognitive Symptoms Derived from Tau Accumulation in Progressive Supranuclear Palsy.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies.

Comparison of three plasma p-tau217 assays to detect PET-confirmed Alzheimer's pathologies.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: October 02, 2025

Advances in PET imaging of protein aggregates associated with neurodegenerative disease.

Advances in PET imaging of protein aggregates associated with neurodegenerative disease.

Journal: Nature reviews. Neurology
Published: July 15, 2025

Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET Study.

Effects of Extended-Release Methylphenidate on Dopamine and Norepinephrine Transporters in Adults With Attention-Deficit/Hyperactivity Disorder: A Longitudinal Dual-Tracer PET Study.

Journal: Psychiatry and clinical neurosciences
Published: July 11, 2025

Quantification of monoamine oxidase B expression with 11C-SL25.1188 for imaging reactive astrocytes in patients with Alzheimer's disease.

Quantification of monoamine oxidase B expression with 11C-SL25.1188 for imaging reactive astrocytes in patients with Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging
Published: July 02, 2025

Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study.

Concurrent Alzheimer's disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study.

Journal: Journal of Alzheimer's disease : JAD
Published: June 20, 2025

A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder.

A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder.

Journal: The international journal of neuropsychopharmacology
Published: May 12, 2025

Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease.

Neuropathological correlations of 18F-florzolotau PET in a case with Pick’s disease.

Journal: EJNMMI research
Published: April 15, 2025
Showing 1-12 of 97

Last Updated: 09/26/2026